| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $40.7M | +59.4% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $85.6M | +23.4% |
| SG&A Expense | $30.5M | +25.1% |
| Operating Income | -$75.5M | -8.3% |
| Pre-tax Income | -$54.5M | -7.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$54.5M | -7.7% |
| EPS (Basic) | -$0.44 |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.7M | +84.2% |
| Short-term Investments | $137.5M | -5.1% |
| Current Assets | $167.1M | +1.4% |
| Total Assets | $177.8M | +2.1% |
| Current Liabilities | $24.4M | -19.3% |
| Total Liabilities | $125.4M | -5.5% |
| Stockholders' Equity | $52.4M | +26.7% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.7M | -52.5% |
| Capital Expenditures | $479K | -32.3% |
| Investing Cash Flow | $6.9M | -72.1% |
| Financing Cash Flow | $49.1M | +1314.4% |
| Free Cash Flow | -$49.2M | -50.7% |
| +2.2% |
| EPS (Diluted) | -$0.50 | +26.5% |